新日本製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 化学 | 4931/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2024/05/31 | 日証協 | 86,658株 | -3.78% | 25,423株 | +9999.99% | 204,488株 | -1.58% | 11,293株 | -9.64% |
| 2024/05/24 | 日証協 | 90,058株 | +0.22% | 200株 | -93.89% | 207,772株 | -20.7% | 12,498株 | -5.4% |
| 2024/05/17 | 日証協 | 89,858株 | -4.74% | 3,272株 | 0% | 262,001株 | -0.38% | 13,212株 | +33.48% |
| 2024/05/10 | 日証協 | 94,329株 | -2.88% | 0株 | 0% | 263,008株 | +0.04% | 9,898株 | +76% |
| 2024/05/02 | 日証協 | 97,129株 | -2.31% | 0株 | -100% | 262,913株 | -0.03% | 5,624株 | -63.75% |
| 2024/04/26 | 日証協 | 99,429株 | +7.34% | 10,300株 | 0% | 263,002株 | +4.25% | 15,513株 | -31.05% |
| 2024/04/19 | 日証協 | 92,629株 | -9.03% | 0株 | -100% | 252,288株 | -1.4% | 22,498株 | +127.09% |
| 2024/04/12 | 日証協 | 101,829株 | -8.04% | 23,974株 | -25.02% | 255,882株 | -2.18% | 9,907株 | +14.33% |
| 2024/04/05 | 日証協 | 110,729株 | -7.65% | 31,974株 | -75.59% | 261,581株 | +103.94% | 8,665株 | -93.67% |
| 2024/03/29 | 日証協 | 119,895株 | +3.72% | 130,996株 | +12.67% | 128,264株 | -51.08% | 136,781株 | +968.6% |
| 2024/03/22 | 日証協 | 115,595株 | -10.13% | 116,267株 | +12.33% | 262,180株 | -0.59% | 12,800株 | +35.46% |
| 2024/03/15 | 日証協 | 128,624株 | -23.54% | 103,509株 | +82.65% | 263,745株 | -1.37% | 9,449株 | -60.65% |
| 2024/03/08 | 日証協 | 168,224株 | -2.51% | 56,672株 | 0% | 267,404株 | +1.91% | 24,015株 | +246.09% |
| 2024/03/01 | 日証協 | 172,557株 | +1.79% | 0株 | -100% | 262,399株 | +1.04% | 6,939株 | -36.54% |
| 2024/02/22 | 日証協 | 169,529株 | -0.93% | 4,500株 | -83.15% | 259,698株 | +0.9% | 10,935株 | +4.05% |
| 2024/02/16 | 日証協 | 171,129株 | -12.25% | 26,713株 | +6.96% | 257,372株 | -3.58% | 10,509株 | +59.23% |
| 2024/02/09 | 日証協 | 195,029株 | -14.09% | 24,974株 | -72.21% | 266,923株 | -8.69% | 6,600株 | -90.48% |
| 2024/02/02 | 日証協 | 227,018株 | +11.22% | 89,874株 | +70.64% | 292,323株 | +8.05% | 69,300株 | +1676.92% |
| 2024/01/26 | 日証協 | 204,118株 | +27.24% | 52,668株 | -22.76% | 270,555株 | -1.77% | 3,900株 | -94.64% |
※株式分割は考慮していませんのでご注意ください。
Page Top